DIRS.INFO The most relevant business & tech news

☆ Jim Cramer looks at why Big Tech keeps going up, sees 2 drug stocks as buys on weakness
▼ + stars: | 2024-12-11 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. A major reason for the uptick in tech, according to Jim Cramer, is there is "no longer an existential crisis at the FTC." As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m.

Persons: Jim Cramer, Stocks, Jim, Donald Trump's, Andrew Ferguson, Apple, Eli Lilly, Ro, Lilly, Myers, Jim Cramer's Organizations: CNBC, Nasdaq, FTC, Biden, Broadcom, Club, Bristol, GE Vernova, Boeing, General Motors, Kroger, Albertsons

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a head-to-head clinical trial, Lilly said in a news release Wednesday. The study, which Lilly funded, is the first randomized, controlled clinical trial comparing the two rival weight loss drugs. Previous studies have shown Zepbound outperforms Wegovy for weight loss, however, those weren’t considered true comparisons as they relied on looking back at existing data. That means, Lilly says, Zepbound provides 47% more weight loss than Wegovy. “The amount of weight loss with both is astounding,” Spratt said.

Persons: Eli Lilly’s, Lilly, Zepbound, Susan Spratt, ” Spratt, haven’t, Eli Lilly, Dr, Christopher McGowan, tirzepatide, Spratt, McGowan, ” Organizations: Nordisk’s Wegovy, Population Health Management, Duke Health, Novo Nordisk Locations: North Carolina, U.S, Puerto Rico, Novo,

☆ Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
▼ + stars: | 2024-12-04 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +6 min

New trial data has cemented Club holding Eli Lilly 's pole position in the highly competitive obesity drug race. The news Eli Lilly's obesity drug Zepbound bested its main rival Wegovy — made by Denmark's Novo Nordisk — in the first head-to-head trial comparing the fast-growing weight loss treatments. Shares of Eli Lilly, a longtime portfolio name, rose more than 2.5% Wednesday, to around $833 apiece. LLY YTD mountain Eli Lilly YTD "I think [Lilly stock] should return to the $900 level," Jim Cramer said Wednesday on the Morning Meeting. A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.

Persons: Eli Lilly, Eli, Zepbound, Wegovy —, Zepound, Lilly, Wegovy, Leerink, Ozempic, Lilly's, Biden, Donald Trump, Robert F, Kennedy Jr, Eli Lilly YTD, Jim Cramer, Dave Ricks, Mounjaro, Jim Cramer's, Jim, Scott Olson Organizations: Denmark's Novo Nordisk —, Novo Nordisk, Analysts, Drug, FDA, Morning, CNBC, Company, Getty Locations: Eli Lilly's, Indianapolis , Indiana

☆ Ditch all the negativity: Here's what can go right to lift each of our 34 stocks
▼ + stars: | 2024-11-29 | by ( Paulina Likos | ) www.cnbc.com time to read: +20 min

To counter that, Jim Cramer has said investors should not lose sight of what can go right for their stocks. Smooth chip updates: AMD needs to successfully carry out its annual release cycle for AI chips. That needs to be sustained to justify Meta's heavy spending on AI chips. Nevertheless, correcting this dynamic should translate into faster revenue growth rates. Palo Alto Networks Bigger deals: Cybersecurity is a secular growth market: As the number of bad actors grows, companies can't afford to not invest in defense.

Persons: Jim Cramer, Abbott, Donald Trump, Trump, Joe Biden, Eaton, Eli Lilly, Eli Lilly's GLP, Lilly, Hurricanes Helene, Milton, Elliott Management's, Elliott, Jim, Linde, Morgan Stanley Lower, Morgan, Biden, –, Jensen Huang, Palo, Stanley Black, Brian Niccol's, Wells, Jim Cramer's, Timothy A, Clary Organizations: Abbott, Devices, Microsoft, AMD, Nvidia, Justice Department, Services, Trump, Apple, Apple Intelligence, Federal, Bristol Myers Squibb, Bristol Myers, Broadcom, Constellation Brands, Modelo, Costco, U.S, Netflix, Coterra Energy, LNG, DuPont, GE Healthcare, GE, Hurricanes, Honeywell Business, Honeywell, Linde, Meta, Facebook, Federal Reserve, GOP, Nvidia's, Industry, Palo Alto, Decker, Starbucks, Walt Disney Parks, TJX, Jim Cramer's Charitable Trust, CNBC, Traders, New York Stock Exchange, Getty Locations: U.S, BlackRock, Corona, China, Dover, –, New York City

☆ Here's our first-quarter earnings report card for 32 stocks in the portfolio
▼ + stars: | 2024-06-21 | by ( Zev Fima | ) www.cnbc.com time to read: +14 min

Most of the earnings reports — 25 out of 32 portfolio names — were ranked as good or great by the Investing Club. Similar to prior quarters, we grouped company results into one of four categories. Meta Platforms : Sales, earnings and cash flow results all topped expectations . However, sales and earnings both outpaced expectations, as did return on tangible common equity, a key consideration when valuing banks. The company also raised its outlook for full-year earnings growth to 25% year-over-year from 20%.

Persons: we're, Dover, Eli Lilly, Blackwell, Abbott, —, Wall, We'll, Morgan Stanley, Nikesh, Stanley Black, Wells, Estee Lauder, Fabrizio Freda, Jim Cramer's, Jim Cramer, Jim, Hock Tan, Broadcom Lucas Jackson Organizations: Investing, Apple, Services, Broadcom, VMware, Coterra, DuPont, Microsoft, Nvidia, Wynn Resorts, Super, Abbott Labs, Web Services, Constellation Brands, Constellation, Ford, Ford Pro, Wall Street, Alto Networks, Procter & Gamble, TJX, GE Healthcare, Honeywell, Linde, Jim Cramer's Charitable, CNBC Locations: Dover, China, Eaton, Las Vegas, China's Macao, billings, Wells Fargo, —

☆ Here are Jim Cramer's rapid-fire takes on 5 stocks in the news Monday
▼ + stars: | 2024-02-05 | by ( Paulina Likos | ) www.cnbc.com time to read: +1 min

Jim Cramer said this deal is Novo's way to "get more product" and addresses the "tremendous shortage" of these high-demand drugs. Shares of Eli Lilly , a stock in the CNBC Investing Club 's portfolio, were also up more than 4% ahead of Tuesday's earnings. Snap – The social media firm laid off 10% of its workforce ahead of Tuesday's earnings. Jim pointed out that Club name Starbucks (SBUX) has also been experiencing the same thing. Jim said buy McDonald's stock on weakness.

Persons: Jim Cramer, Eli Lilly, Lilly, Cramer, Cigna –, Cantor Fitzgerald, Jim Organizations: Nordisk, Catalent, CNBC, Microsoft, RBC Capital, Humana, Starbucks, Mattel –, JPMorgan, Vision, Apple Locations: Danish, Israel

☆ Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks
▼ + stars: | 2023-12-05 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

CNBC's Jim Cramer on Tuesday said he thinks Wall Street has made some poor decisions when evaluating mega cap stocks. "Look, on any given day, we're giving, getting these imperfections, these mistakes, these juvenile, uninformed moves," he said. Cramer pointed to tech giant Apple , which he said opened down on Tuesday due to a market-wide decline. But its stock changed course after the company announced its recently approved weight loss treatment Zepound is now available at pharmacies. These "mistakes" can bode well for investors who might want to buy shares of high quality stocks at lower prices.

Persons: CNBC's Jim Cramer, Cramer, Hai, Eli Lilly, Eli Lilly's, bode Organizations: Apple, Foxconn

Search resuls for: "Zepound"

7 mentions found